Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutch Parkinson GBA Ambroxol trial (DUPARG-AMBROXOL)
2021-001833-38Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (GBA-PD) comparing Ambroxol with Placebo (2 arms). Started Mar 2023; status: active.
02
Drugs
ambroxol
03
Conditions
Parkinson's disease (GBA-PD)
Beyond the preview
Go deeper on 2021-001833-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001833-38.